Insights

Biosimilar

IPR Appeal Dismissed After Biosimilar Development Discontinued, PTAB Litigation Blog

Visit the PTAB Litigation Blog.

Article III of the Constitution imposes a "case or controversy" limitation on the jurisdiction of federal courts: an actual case or controversy must exist between the parties at all stages of the federal court proceedings, including appeals. The Supreme Court has articulated a number of justiciability doctrines, such as standing and mootness, to delineate this constitutional limit. As applied to PTAB litigation, the Federal Circuit has dismissed appeals brought by petitioners after unsuccessful PTAB trials for lack of standing in cases where the petitioner fails to establish an "injury in fact."

Read the full article at ptablitgationblog.com.

Insights by Jones Day should not be construed as legal advice on any specific facts or circumstances. The contents are intended for general information purposes only and may not be quoted or referred to in any other publication or proceeding without the prior written consent of the Firm, to be given or withheld at our discretion. To request permission to reprint or reuse any of our Insights, please use our “Contact Us” form, which can be found on our website at www.jonesday.com. This Insight is not intended to create, and neither publication nor receipt of it constitutes, an attorney-client relationship. The views set forth herein are the personal views of the authors and do not necessarily reflect those of the Firm.